CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO
Depression Treatment in Westminster, CO
Depression is not simply a shortage of serotonin. That explanation — the one behind decades of prescribing — is now understood to be far too narrow. Depression has multiple biological drivers, many of which have nothing to do with neurotransmitter reuptake and cannot be reached by medication alone.
Medication and therapy are genuine and often important parts of depression treatment. Our naturopathic approach does not replace them. It identifies and addresses the biological contributors that medication was never designed to reach — the inflammation, the nutritional deficiencies, the thyroid and hormonal factors, the gut dysbiosis, the sleep disruption, and the metabolic dysfunction that in many people are driving or significantly worsening the depression they experience.
Same-Day & Same-Week Appointments Available
WE UNDERSTAND WHAT YOU'RE GOING THROUGH
Depression is not sadness. It is the absence of something — the flattening of a range that used to feel available to you, replaced by a heaviness that is present even when nothing specific is wrong.
The flatness that colors everything equally gray regardless of what the day contains. The effort required for things that should take no effort at all — getting up, responding to a message, preparing food. The way you can watch something that used to bring pleasure and feel nothing, and know that you felt something before and cannot reach that place now. The exhaustion that is not tiredness, that sleep does not touch. The thoughts that slow, that take longer to form and feel less clear. The loss of interest that extends beyond activities to relationships, to the future, to a sense of direction. You may be on medication that has helped somewhat — the sharpest edges smoothed — but that has not returned you to the person you were before. Or you may be managing without medication and looking for whether there is something more specific that could be done. In either case, what is rarely offered is a thorough biological investigation of what is producing or worsening the depression. Not a questionnaire. A real assessment of the thyroid, the gut, the inflammatory markers, the nutritional status, the blood sugar, the hormonal picture — the internal environment that determines, in ways that are measurable and modifiable, how accessible your mood is.
HOW DEPRESSION PRESENTS
-
Persistent low mood, emptiness, or emotional flatness lasting most of the day, most days
-
Loss of interest or pleasure in activities that previously brought enjoyment
-
Fatigue and low energy disproportionate to activity level
-
Sleep disturbance: difficulty falling asleep, waking early, or sleeping excessively without feeling rested
-
Cognitive slowing: poor concentration, word-finding difficulties, and memory problems
-
Changes in appetite and weight — either loss or gain
-
A sense of worthlessness, hopelessness, or guilt that is not proportionate to circumstances
-
Withdrawal from relationships, responsibilities, and activities that require engagement with the world
THE PAIN CONNECTION
Depression and chronic pain share the same neurobiological terrain. Both involve a sensitized nervous system, elevated systemic inflammation, disrupted sleep, and an HPA axis under chronic stress. They feed each other: pain amplifies depression through suffering, limitation, and loss of identity, while depression amplifies pain through central sensitization and reduced pain tolerance. The two conditions almost never respond fully to treatment that addresses only one of them.
At True Health Centers, treating depression is treating pain — and treating pain is treating depression. They are not separate problems. They are two expressions of the same disturbed internal environment.
WHAT YOU PROBABLY HAVEN'T BEEN TOLD
The leading research model for depression has shifted. Inflammation, not serotonin deficiency alone, is now understood to be one of the primary biological drivers of depression — which explains why antidepressants work partially for many people and not at all for others.
THE BIOLOGY OF DEPRESSION — WHAT RESEARCH IN THE PAST TWENTY YEARS HAS REVEALED ABOUT WHAT IS ACTUALLY HAPPENING
For decades, depression was explained almost exclusively as a deficiency of serotonin — the "chemical imbalance" model that justified the widespread prescribing of selective serotonin reuptake inhibitors. This model was always an oversimplification, and the research of the past twenty years has made its limitations increasingly clear. SSRIs work for a significant proportion of depressed patients — but for roughly 30 to 40 percent, they produce inadequate or no improvement. The "chemical imbalance" framing does not explain this variation. The inflammatory model of depression does. Elevated inflammatory markers — particularly interleukin-6, tumor necrosis factor, and CRP — are consistently found in depressed patients, and their levels correlate with depression severity. Inflammatory cytokines directly disrupt serotonin metabolism, reduce dopamine availability, alter brain plasticity, impair the hypothalamic-pituitary-adrenal axis, and produce the fatigue, cognitive slowing, and anhedonia that characterize depression. In patients with inflammatory depression, anti-inflammatory interventions produce improvement that antidepressants alone do not — because the driver of the depression has never been the neurotransmitter reuptake mechanism that the medication addresses.
The sources of that inflammatory drive are identifiable. Gut dysbiosis and intestinal permeability are among the most important — the gut produces the majority of the body's serotonin and is the immune system's largest interface, and a dysbiotic, inflamed gut drives systemic neuroinflammation through the gut-brain axis. Metabolic dysfunction — elevated blood sugar, insulin resistance — produces inflammatory cytokines that directly reach brain tissue. Nutritional deficiencies in omega-3 fatty acids, vitamin D, folate, B12, magnesium, and zinc all impair neurotransmitter synthesis, neuroplasticity, and the immune regulatory mechanisms that prevent neuroinflammation. Thyroid dysfunction — even in the range that standard testing considers "borderline" — produces depression as a direct physiological consequence. Identifying and addressing these specific contributors produces improvement that medication management alone cannot achieve for many patients.
The gut-brain axis — how the gut drives depression through neuroinflammation
The gut contains the enteric nervous system — over 100 million neurons that communicate constantly with the brain through the vagus nerve. The gut microbiome produces the majority of the body's serotonin, significant amounts of GABA, and a range of neuroactive compounds that directly influence mood, cognition, and stress reactivity. When the microbiome is dysbiotic — as it is in the majority of patients with depression, based on an extensive and growing body of research — serotonin production is reduced, neuroinflammatory compounds increase, and vagal nerve signaling that normally supports parasympathetic calm and emotional regulation is disrupted. The gut also produces short-chain fatty acids from dietary fiber fermentation that protect the blood-brain barrier and reduce neuroinflammation. Dysbiosis reduces these protective compounds. Restoring the gut microbiome is therefore a direct neurological intervention with specific relevance to the biology of depression — not a peripheral wellness consideration.
Randomized controlled trials of probiotic supplementation in depression have demonstrated measurable improvements in depressive symptoms, inflammatory markers, and stress hormone levels — providing direct evidence for the gut-brain-mood connection.
Omega-3 fatty acids — the most evidence-supported nutritional intervention in depression
Omega-3 fatty acids, particularly EPA (eicosapentaenoic acid), have accumulated one of the largest and most consistent bodies of evidence of any nutritional intervention in psychiatry. A comprehensive meta-analysis of clinical trials found that EPA-rich omega-3 supplementation produces significant antidepressant effects, with a magnitude comparable to antidepressant medication in some populations. The mechanisms are coherent and multiple: EPA reduces the production of inflammatory cytokines that drive neuroinflammation, improves neuronal membrane fluidity that supports neurotransmitter receptor function, reduces cortisol reactivity, and supports the brain-derived neurotrophic factor (BDNF) that is critical for neuroplasticity and mood regulation. Low omega-3 status is extremely prevalent in Western populations and is one of the most readily correctable nutritional contributors to depression available — yet it is almost never checked or supplemented as part of standard depression management.
EPA specifically — rather than DHA — appears to be the more active antidepressant omega-3. Supplements with a higher EPA to DHA ratio produce better mood outcomes in most clinical studies.
Thyroid, hormones, and the biological depression that standard care misses
Hypothyroidism — including subclinical hypothyroidism with TSH in the upper normal range — produces depression as a direct physiological consequence through reduced serotonin receptor sensitivity, impaired dopamine metabolism, and neurological slowing. Many patients diagnosed with depression and placed on antidepressants have an unidentified thyroid contribution that makes their medication less effective. In women, the hormonal fluctuations of the perimenopausal transition, PMOS-related hormonal dysregulation, and PMDD produce depression through direct neurobiological mechanisms that antidepressants only partially address. Vitamin D deficiency — extraordinarily common in Colorado despite the altitude — is independently associated with depression and impairs the very brain plasticity and immune regulatory pathways that determine mood resilience. Blood sugar dysregulation produces mood instability and depressive episodes through direct neurochemical effects that stabilizing glucose can dramatically reduce. These are not alternative explanations. They are additional biological contributors that a comprehensive assessment identifies and a comprehensive treatment addresses.
The proportion of depression cases with a significant biological contributor that is modifiable through naturopathic intervention is substantially larger than most patients — or their prescribers — have been led to believe.
OUR APPROACH
Conventional care versus our approach
We fully support medication and therapy when they are clinically indicated, and we communicate with the patient's psychiatrist, psychologist, or primary care provider as a collaborative partner. Our role is to investigate and address the biological contributors to depression that medication cannot reach — the inflammatory, nutritional, hormonal, and gut health factors that determine whether the medication works, and that in many patients are doing as much to sustain the depression as any neurotransmitter imbalance.
The conventional approach
What most patients experience
-
Depression assessed using symptom questionnaires and clinical interview; severity classified as mild, moderate, or severe
-
SSRI or SNRI medication prescribed as first-line pharmacological management
-
Referral to cognitive-behavioral therapy or other psychotherapy for moderate to severe cases
-
General advice to exercise, improve sleep, and reduce stress
-
Inflammatory markers, thyroid function, gut health, omega-3 status, vitamin D, B12, folate, blood sugar, and hormonal contributors not systematically investigated as part of depression management
-
When medication is partially effective, dose increased or second agent added — without investigation of why the first medication produced an incomplete response
Standard depression care addresses the neurotransmitter picture through medication and the psychological picture through therapy. Its limitation is that it does not investigate or address the inflammatory, metabolic, nutritional, and hormonal biology that determines whether those approaches will work and that in many patients is sustaining the depression independently of brain chemistry.
What we do differently
-
Comprehensive biological assessment: inflammatory markers (hsCRP, IL-6), complete thyroid panel including antibodies, vitamin D, omega-3 index, B12, folate, magnesium, zinc, fasting insulin, HbA1c, sex hormone panel where relevant, and gut health markers
-
High-EPA omega-3 supplementation at therapeutic doses: the most evidence-supported single nutritional intervention in depression, addressing both the neuroinflammatory component and the neurotransmitter receptor environment simultaneously
-
Gut microbiome restoration: addressing the primary source of neuroinflammation and serotonin synthesis impairment — targeted probiotics, prebiotics, and dietary fiber to rebuild the gut-brain axis signaling that mood resilience depends on
-
Thyroid optimization, hormonal assessment, and blood sugar stabilization: identifying and treating the biological conditions that produce depressive symptoms through direct physiological mechanisms independent of neurotransmitter imbalance
-
Vitamin D, B vitamins, magnesium, and zinc: correcting the nutritional deficiencies that impair serotonin and dopamine synthesis, reduce neuroplasticity, and sustain the inflammatory tone underlying depression
-
Autonomic regulation through constitutional hydrotherapy and chiropractic care: directly shifting the nervous system from chronic sympathetic dominance toward the parasympathetic recovery state — treating the physiological stress state that sustains the neurobiological environment of depression
We do not prescribe psychiatric medications and we do not replace mental health care. We provide the biological investigation and treatment that identifies the specific physiological contributors to depression that medication cannot reach — and that in many patients account for much of why they have not responded as fully as expected to standard treatment.
WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH
Standard depression care targets the neurotransmitter system. Our approach investigates why the neurotransmitter system is dysregulated — the gut dysbiosis reducing serotonin synthesis and driving neuroinflammation through the gut-brain axis, the systemic inflammation from metabolic dysfunction reaching the brain and disrupting mood circuits, the omega-3 deficiency impairing neuronal membrane function and anti-inflammatory brain chemistry, the vitamin D and B vitamin deficiencies impairing neuroplasticity and neurotransmitter co-factor production, and the thyroid and hormonal contributors producing depression as a direct physiological output. When these are identified and addressed, antidepressants work better, therapy produces more durable insight, and patients recover a dimension of mood resilience that medication alone was never able to provide. For patients who also have chronic pain, we treat both simultaneously — because the same inflammatory and nervous system environment that produces depression produces amplified pain, and addressing it comprehensively is the only approach that improves both.
DEPRESSION AND THE REST OF YOUR HEALTH
Depression rarely travels alone. It co-occurs with chronic pain, gut disorders, autoimmune conditions, hormonal dysfunction, and metabolic disease at rates that are far too high to be coincidental — because they share the same biological terrain.
At True Health Centers, we regularly see patients whose depression has never been fully addressed because the gut dysbiosis, thyroid issue, hormonal imbalance, or metabolic dysfunction driving it was never identified. When we identify and treat these contributors alongside the structural pain treatment that brought the patient to us, the improvement in mood is often one of the most meaningful outcomes of the whole treatment course.
Depression and chronic pain — shared neurobiology
Depression and chronic pain share the same central sensitization mechanism — a nervous system that has become hyperreactive to signals it should be able to modulate. The systemic inflammation that drives neuroinflammation in depression also sensitizes peripheral pain receptors. The HPA axis dysregulation that sustains depression also reduces the body's endogenous pain inhibition through descending neural pathways. Treating depression biologicaly reduces the inflammatory and neurological burden on the pain system — and addressing pain removes one of the most powerful continuous activators of the neurological state that depression depends on.
Depression, IBS, and the gut connection
IBS and depression coexist at rates that exceed chance dramatically. Both are driven by the same gut-brain axis dysregulation — the enteric nervous system sensitization, the microbiome-driven neuroinflammation, and the vagal nerve signaling disruption that connects gut dysfunction to mood dysfunction. When we restore gut health in patients presenting primarily with IBS, the improvement in mood and energy is frequently the feature they find most meaningful — because we have treated the common upstream driver of both conditions simultaneously.
IR sauna, exercise, and neuroplasticity
Exercise is the single most evidence-supported non-pharmaceutical intervention for depression, with effect sizes comparable to antidepressant medication in multiple clinical trials. It works through BDNF induction — stimulating the growth of new neural connections in the mood-regulating circuits of the brain. Infrared sauna produces similar BDNF-related benefits and reduces systemic inflammatory markers independently, while activating the parasympathetic recovery state that chronic depression suppresses. For patients whose depression severity or physical pain limits their ability to exercise adequately, sauna therapy provides a meaningful neurobiological benefit during the period when other interventions are building capacity.
TAKE THE NEXT STEP
Your depression has biological drivers that medication cannot reach. We find them — and address them alongside your existing care.
Comprehensive biological assessment, omega-3 and nutritional support, gut microbiome restoration, thyroid and hormonal evaluation, and integrated pain care.
Not sure where to begin? Give us a call and we'll help you choose the best first step.